SART3, regulated by p53, is a biomarker for diagnosis, prognosis and immune infiltration in hepatocellular carcinoma

Jusen Nong; Kejian Yang; Tianman Li; Chenlu Lan; Xin Zhou; Junqi Liu; Haixiang Xie; Jianzhu Luo; Xiwen Liao; Guangzhi Zhu; Tao Peng

doi:doi:10.18632/aging.204978

← Back

Research Paper Volume 15, Issue 16 pp 8408—8432

SART3, regulated by p53, is a biomarker for diagnosis, prognosis and immune infiltration in hepatocellular carcinoma

Figure 4. Validation of SART3 in patients with HCC in Guangxi. (A) Representative IHC images showing the in situ expression of SART3 in HCC and adjacent liver tissues. (B) Paired plots showing immunostaining scores of SART3 in HCC and adjacent liver tissues in the Guangxi cohort. (C) Diagnostic ROC curves of SART3 in the Guangxi cohort. (D) OS of SART3^high and SART3^low groups in the Guangxi cohort based on immunohistochemical staining scores.